Alan R. Fritzberg

Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.

Alan R. Fritzberg, S. Kasina, Dennis Eshima et al. · PubMed · 1986 · 302 citations

Medicine, Nuclear Medicine, Pharmacokinetics +17

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations

Medicine, Oncology, Pharmacology +17

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

D. Scott Wilbur, S. W. HADLEY, Mark D. Hylarides et al. · PubMed · 1989 · 172 citations

Medicine, Oncology, Radiation Oncology +16

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Alan R. Fritzberg, Paul G. Abrams, Paul L. Beaumier et al. · Proceedings of the National Academy of Sciences · 1988 · 161 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacology +17

Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.

Alan R. Fritzberg, Donald M. Lyster, David Dolphin · PubMed · 1977 · 152 citations

Natural Sciences, Nuclear Medicine, Pharmaceutics +12